当前位置： SCI文献检索 > CIRCULATION期刊下所有文献 > Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

Abstract：

BACKGROUND:Red blood cell transfusion can both benefit and harm. To inform decisions about transfusion, we aimed to quantify associations of transfusion with clinical outcomes and cost in patients having cardiac surgery. METHODS AND RESULTS:Clinical, hematology, and blood transfusion databases were linked with the UK population register. Additional hematocrit information was obtained from intensive care unit charts. Composite infection (respiratory or wound infection or septicemia) and ischemic outcomes (myocardial infarction, stroke, renal impairment, or failure) were prespecified as coprimary end points. Secondary outcomes were resource use, cost, and survival. Associations were estimated by regression modeling with adjustment for potential confounding. All adult patients having cardiac surgery between April 1, 1996, and December 31, 2003, with key exposure and outcome data were included (98%). Adjusted odds ratios for composite infection (737 of 8516) and ischemic outcomes (832 of 8518) for transfused versus nontransfused patients were 3.38 (95% confidence interval [CI], 2.60 to 4.40) and 3.35 (95% CI, 2.68 to 4.35), respectively. Transfusion was associated with increased relative cost of admission (any transfusion, 1.42 times [95% CI, 1.37 to 1.46], varying from 1.11 for 1 U to 3.35 for >9 U). At any time after their operations, transfused patients were less likely to have been discharged from hospital (hazard ratio [HR], 0.63; 95% CI, 0.60 to 0.67) and were more likely to have died (0 to 30 days: HR, 6.69; 95% CI, 3.66 to 15.1; 31 days to 1 year: HR, 2.59; 95% CI, 1.68 to 4.17; >1 year: HR, 1.32; 95% CI, 1.08 to 1.64). CONCLUSIONS:Red blood cell transfusion in patients having cardiac surgery is strongly associated with both infection and ischemic postoperative morbidity, hospital stay, increased early and late mortality, and hospital costs.

journal_name

Circulation

journal_title

Circulation

authors

Murphy GJ,Reeves BC,Rogers CA,Rizvi SI,Culliford L,Angelini GD

doi

10.1161/CIRCULATIONAHA.107.698977

subject

Has Abstract

pub_date

2007-11-27 00:00:00

pages

2544-52

issue

eissn

0009-7322

issn

1524-4539

pii

CIRCULATIONAHA.107.698977

journal_volume

116

pub_type

杂志文章

在线工具

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.